New drug prolongs ALS patient survival in trial
An experimental medication that was recently shown to slow the progression of ALS has now demonstrated the potential to also prolong patient survival.
Harvard Gazette •
harvard
Oct. 16, 2020 • ~4 min
Oct. 16, 2020 • ~4 min
Tags: harvard-medical-school health-medicine als massachusetts-general-hospital mgh lou-gehrigs-disease sean-m-healey-amg-center-for-als
Page 1 of 1